Advanced Cardiac Therapeutics
Santa Clara, US · Delaware corporation · 1 known investors
Founders & leadership
PM
Philippe MarcoExecutive
DK
Doug KooExecutive
Board
RD
JK
Justin KleinBoard director
MP
Michael PedersonBoard director
WO
William OlsonBoard director
AC
Aris ConstantinidesBoard director
DR
Duke RohlenBoard director
RT
Roy TanakaBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$52.3M disclosed across 2 rounds · 2014–2017
▶$45MraisedMay 2017 · 4 investors · Other Health CareRule 506(b)
▶$45MraisedMay 2017 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Duke RohlenDirector
- Philippe MarcoExecutive Officer
- Doug KooExecutive Officer
- Roy TanakaDirector
- Ryan DrantDirector
- Justin KleinDirector
- Offering amount
- $46M
- Amount sold
- $45M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.3MraisedApr 2014 · 6 investors · OtherRule 506(b)
▶$7.3MraisedApr 2014 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Duke RohlenExecutive Officer, Director
- Roy TanakaDirector
- Michael PedersonDirector
- Justin KleinDirector
- William OlsonDirector
- Aris ConstantinidesDirector
- Doug KooExecutive Officer
- Offering amount
- $8M
- Amount sold
- $7.3M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Advanced Cardiac Therapeutics's investors?
- Advanced Cardiac Therapeutics's investors include Questa Capital.
- How much funding has Advanced Cardiac Therapeutics raised?
- Advanced Cardiac Therapeutics has disclosed $52.3M raised across 2 rounds.
- Where is Advanced Cardiac Therapeutics headquartered?
- Advanced Cardiac Therapeutics is headquartered in Santa Clara, US.